Working Opportunity Fund is a venture capital fund specialized in early-stage investments.
Management of the Working Opportunity Fund transferred to PenderFund Capital on March 1, 2019
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Sep 29, 2011
MSI Methylation Sciences
|
Series A | €13.50M | Biotechnology | — |
Apr 7, 2009
Teradici
|
Series C | $17M | Enterprise Software | — |
Feb 14, 2007
Teradici
|
Series B | $18M | Enterprise Software | — |
Feb 3, 2005
GenoLogics
|
Series A | $5M | Biotechnology | — |
Oct 29, 2003
OncoGenex
|
Post-IPO Equity | $11.50M | Biotechnology | Yes |
Working Opportunity Fund has had 4 exits. Working Opportunity Fund most notable exits include AppNeta , Teradici
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Dec 7, 2021 | AppNeta | M&A | Cloud Computing | Detail |
Jul 27, 2021 | Teradici | M&A | Enterprise Software | Detail |
Aug 4, 2015 | GenoLogics | M&A | Biotechnology | Detail |
Oct 20, 1995 | OncoGenex | M&A | Biotechnology | Detail |